What one share of Arvinas holds
We are a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through our PROteolysis TArgeting Chimera, or PROTAC, protein degradation platform, we are pioneering the development of a new class of therapeutics designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Arvinas’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | $0.14 |
|---|---|
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$3.10 |
| Cash and investments | $8.70 |
| Debt | $0.01 |
| Book value | $8.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $3.99 | −$15.08 | $0.53 | $2.16 | — | −$32.27 |
| 2018 | $1.52 | −$25.45 | $0.30 | −$2.01 | — | — |
| 2019 | $1.31 | −$2.14 | $0.19 | −$1.43 | — | $5.89 |
| 2020 | $0.66 | −$3.02 | $0.16 | −$2.43 | — | $13.24 |
| 2021 | $1.07 | −$3.82 | $0.09 | $11.09 | — | $14.75 |
| 2022 | $2.47 | −$5.31 | $0.13 | −$5.27 | — | $10.62 |
| 2023 | $1.41 | −$6.62 | $0.05 | −$6.32 | — | $9.71 |
| 2024 | $3.66 | −$2.77 | $0.03 | −$3.63 | — | $8.16 |
| 2025 | $3.70 | −$1.14 | $0.03 | −$3.89 | — | $6.83 |
Common questions about Arvinas
How much does one share of Arvinas earn?
Over the last 12 months, each share of Arvinas earned $0.14 of profit.
Does Arvinas pay a dividend?
Arvinas didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Arvinas’s book value per share?
Arvinas’s book value is $8.61 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Arvinas have?
Each share of Arvinas has $8.70 of cash and investments and $0.01 of debt, as of June 30, 2026.
What is Arvinas’s free cash flow per share?
−$3.10 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Arvinas bought back shares?
Arvinas’s share count rose about 3636% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.